Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
17/11/2025 14:09
Windtree Therapeutics Inc WINT.PK: WINDTREE THERAPEUTICS ANNOUNCES IT MAY RECEIVE LICENSE AGREEMENT PAYMENTS FROM ITS LICENSEE FOR RENEWED ACUTE PULMONARY DEVELOPMENT BY THE LICENSEE WINDTREE THERAPEUTICS INC - LICENSE AGREEMENT COULD PAY UP TO $78.9 MILLION Source text: ID:nGNXbjhXkv Further company coverage: WINT.PK
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study